TMO
Income statement / Annual
Last year (2024), Thermo Fisher Scientific Inc.'s total revenue was $42.88 B,
an increase of 0.05% from the previous year.
In 2024, Thermo Fisher Scientific Inc.'s net income was $6.34 B.
See Thermo Fisher Scientific Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$42.88 B |
$42.86 B |
$44.92 B |
$39.21 B |
$32.22 B |
$25.54 B |
$24.36 B |
$20.92 B |
$18.27 B |
$16.97 B |
| Cost of Revenue |
$25.15 B
|
$25.66 B
|
$25.90 B
|
$19.58 B
|
$16.19 B
|
$14.20 B
|
$13.37 B
|
$11.24 B
|
$9.69 B
|
$9.13 B
|
| Gross Profit |
$17.73 B
|
$17.19 B
|
$19.01 B
|
$19.63 B
|
$16.03 B
|
$11.34 B
|
$10.99 B
|
$9.68 B
|
$8.58 B
|
$7.84 B
|
| Gross Profit Ratio |
0.41
|
0.4
|
0.42
|
0.5
|
0.5
|
0.44
|
0.45
|
0.46
|
0.47
|
0.46
|
| Research and Development Expenses |
$1.39 B
|
$1.34 B
|
$1.47 B
|
$1.41 B
|
$1.18 B
|
$1.00 B
|
$967.00 M
|
$888.00 M
|
$754.80 M
|
$692.30 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$8.68 B
|
$8.41 B
|
$9.02 B
|
$7.91 B
|
$6.95 B
|
$6.06 B
|
$6.03 B
|
$5.41 B
|
$4.87 B
|
$4.57 B
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$20.00 M
|
$121.00 M
|
$110.00 M
|
$96.20 M
|
$85.40 M
|
| Operating Expenses |
$10.07 B
|
$9.75 B
|
$10.49 B
|
$9.32 B
|
$8.13 B
|
$7.09 B
|
$7.12 B
|
$6.41 B
|
$5.72 B
|
$5.34 B
|
| Cost And Expenses |
$35.22 B
|
$35.41 B
|
$36.39 B
|
$28.89 B
|
$24.32 B
|
$21.28 B
|
$20.49 B
|
$17.65 B
|
$15.42 B
|
$14.47 B
|
| Interest Income |
$1.08 B
|
$879.00 M
|
$272.00 M
|
$43.00 M
|
$65.00 M
|
$224.00 M
|
$137.00 M
|
$81.00 M
|
$48.40 M
|
$30.60 M
|
| Interest Expense |
$1.65 B
|
$1.49 B
|
$726.00 M
|
$536.00 M
|
$553.00 M
|
$676.00 M
|
$667.00 M
|
$592.00 M
|
$469.60 M
|
$414.90 M
|
| Depreciation & Amortization |
$3.11 B
|
$3.41 B
|
$3.38 B
|
$2.59 B
|
$2.33 B
|
$2.28 B
|
$2.27 B
|
$2.03 B
|
$1.76 B
|
$1.69 B
|
| EBITDA |
$11.80 B |
$11.20 B |
$11.94 B |
$11.97 B |
$10.11 B |
$7.02 B |
$6.20 B |
$5.05 B |
$4.25 B |
$4.04 B |
| EBITDA Ratio |
0.28
|
0.26
|
0.27
|
0.31
|
0.31
|
0.27
|
0.25
|
0.24
|
0.23
|
0.24
|
| Operating Income Ratio |
0.18
|
0.17
|
0.19
|
0.26
|
0.25
|
0.17
|
0.16
|
0.16
|
0.16
|
0.15
|
| Total Other Income/Expenses Net |
-$667.00 M
|
-$1.21 B
|
-$862.00 M
|
-$1.48 B
|
-$670.00 M
|
-$189.00 M
|
-$610.00 M
|
-$838.00 M
|
-$835.00 M
|
-$558.10 M
|
| Income Before Tax |
$7.00 B
|
$6.24 B
|
$7.66 B
|
$8.84 B
|
$7.23 B
|
$4.07 B
|
$3.26 B
|
$2.43 B
|
$2.02 B
|
$1.94 B
|
| Income Before Tax Ratio |
0.16
|
0.15
|
0.17
|
0.23
|
0.22
|
0.16
|
0.13
|
0.12
|
0.11
|
0.11
|
| Income Tax Expense |
$657.00 M
|
$284.00 M
|
$703.00 M
|
$1.11 B
|
$850.00 M
|
$374.00 M
|
$324.00 M
|
$201.00 M
|
-$1.40 M
|
-$43.90 M
|
| Net Income |
$6.34 B
|
$6.00 B
|
$6.95 B
|
$7.73 B
|
$6.38 B
|
$3.70 B
|
$2.94 B
|
$2.23 B
|
$2.02 B
|
$1.98 B
|
| Net Income Ratio |
0.15
|
0.14
|
0.15
|
0.2
|
0.2
|
0.14
|
0.12
|
0.11
|
0.11
|
0.12
|
| EPS |
16.58 |
15.53 |
17.73 |
19.61 |
16.1 |
9.24 |
7.31 |
5.64 |
5.12 |
4.96 |
| EPS Diluted |
16.53 |
15.45 |
17.64 |
19.46 |
15.98 |
9.17 |
7.24 |
5.59 |
5.09 |
4.92 |
| Weighted Average Shares Out |
$382.00 M
|
$386.00 M
|
$392.00 M
|
$394.00 M
|
$396.00 M
|
$400.00 M
|
$402.00 M
|
$395.00 M
|
$394.80 M
|
$398.70 M
|
| Weighted Average Shares Out Diluted |
$383.00 M
|
$388.00 M
|
$394.00 M
|
$397.00 M
|
$399.00 M
|
$403.00 M
|
$406.00 M
|
$398.00 M
|
$397.40 M
|
$401.90 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
